Final answer:
A pharmacy's Quality Improvement Program requires a robust pharmacovigilance system for post-market safety surveillance, compliance with FDA regulations and testing, risk management plans, and regular quality control checks to ensure the safe and effective dispensing of medicines.
Step-by-step explanation:
As a part of a mandatory Quality Improvement Program (QIP) to address errors, a pharmacy must have certain practices and systems in place:
- A robust pharmacovigilance system to continuously monitor the safety and efficacy of medicines, with processes to report adverse drug reactions and evaluate long-term safety in various patient subgroups.
- Compliance with Food and Drug Administration (FDA) regulations, which involves ensuring the medicines sold have been rigorously tested and approved for market.
- Implementation of risk management plans and, if required by the FDA, conducting additional clinical trials known as Phase IV trials.
- Routine quality control checks, such as those performed by a quality control chemist, to assure the accuracy and precision of medication dispensing equipment.
These measures ensure that pharmacies can effectively manage risks and maintain the high standards of safety and efficacy for all medications dispensed.